Sabra Healthcare REIT (NASDAQ:SBRA – Free Report) had its price objective lifted by Truist Financial from $22.00 to $24.00 in a research note issued to investors on Wednesday morning,Benzinga reports. They currently have a buy rating on the real estate investment trust’s stock.
A number of other brokerages have also issued reports on SBRA. Scotiabank lowered their target price on shares of Sabra Healthcare REIT from $22.00 to $19.00 and set a “sector perform” rating for the company in a research note on Thursday, June 18th. Citizens Jmp lifted their price objective on shares of Sabra Healthcare REIT from $23.00 to $25.00 and gave the company a “market outperform” rating in a report on Wednesday. Citigroup reissued a “market outperform” rating on shares of Sabra Healthcare REIT in a research report on Wednesday. Barclays assumed coverage on shares of Sabra Healthcare REIT in a research note on Tuesday, July 7th. They issued an “overweight” rating and a $21.00 target price on the stock. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of Sabra Healthcare REIT in a research report on Wednesday. Eight investment analysts have rated the stock with a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $22.25.
Check Out Our Latest Research Report on SBRA
Sabra Healthcare REIT Trading Up 1.5%
Sabra Healthcare REIT (NASDAQ:SBRA – Get Free Report) last posted its quarterly earnings data on Wednesday, April 29th. The real estate investment trust reported $0.16 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.16. The company had revenue of $211.74 million during the quarter, compared to analysts’ expectations of $209.20 million. Sabra Healthcare REIT had a return on equity of 5.60% and a net margin of 19.22%.Sabra Healthcare REIT’s revenue was up 20.9% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.37 EPS. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. On average, sell-side analysts expect that Sabra Healthcare REIT will post 1.5 earnings per share for the current year.
Sabra Healthcare REIT Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Friday, May 29th. Stockholders of record on Friday, May 15th were paid a dividend of $0.30 per share. The ex-dividend date was Friday, May 15th. This represents a $1.20 annualized dividend and a dividend yield of 5.4%. Sabra Healthcare REIT’s dividend payout ratio (DPR) is currently 190.48%.
Institutional Investors Weigh In On Sabra Healthcare REIT
Several hedge funds have recently modified their holdings of SBRA. Wedge Capital Management L L P NC increased its holdings in Sabra Healthcare REIT by 12.8% during the second quarter. Wedge Capital Management L L P NC now owns 245,826 shares of the real estate investment trust’s stock valued at $4,796,000 after buying an additional 27,822 shares during the period. Hennion & Walsh Asset Management Inc. lifted its stake in shares of Sabra Healthcare REIT by 18.5% during the 2nd quarter. Hennion & Walsh Asset Management Inc. now owns 121,559 shares of the real estate investment trust’s stock worth $2,372,000 after purchasing an additional 18,954 shares during the last quarter. Versant Capital Management Inc boosted its position in Sabra Healthcare REIT by 70.0% during the second quarter. Versant Capital Management Inc now owns 1,465 shares of the real estate investment trust’s stock valued at $29,000 after purchasing an additional 603 shares in the last quarter. Western Wealth Management LLC bought a new stake in Sabra Healthcare REIT during the first quarter valued at about $294,000. Finally, Pacer Advisors Inc. grew its stake in Sabra Healthcare REIT by 21.4% in the first quarter. Pacer Advisors Inc. now owns 35,554 shares of the real estate investment trust’s stock valued at $684,000 after purchasing an additional 6,266 shares during the last quarter. Hedge funds and other institutional investors own 99.40% of the company’s stock.
About Sabra Healthcare REIT
Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.
Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.
Read More
- Five stocks we like better than Sabra Healthcare REIT
- AMD and Cerbras Create A New Blueprint For Hardware
- Intel Earnings Reveal Whether the Chip Selloff Created a Buy
- CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test
- Plugging In: How Kinder Morgan Powers Up Profits
Receive News & Ratings for Sabra Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.
